The gut is not simply a digestive organ. Approximately 70–80% of the body's immune system is housed in the tissue surrounding the gastrointestinal tract. The intestinal microbiome directly regulates immune responses, inflammation levels, neurotransmitter production, and much of the body's response to infection.
When Lyme disease affects the gut, it sets off a cascade that extends far beyond digestion. Immune regulation breaks down. Inflammation becomes self-perpetuating. The nervous system is affected through the gut-brain axis. Understanding this chain of effects is essential to understanding why gut health is so central to both the experience and the recovery from tick-borne illness.
How Lyme disease affects the gut
Borrelia burgdorferi does not simply circulate in the bloodstream. Research has confirmed that the spirochete can directly invade the gastrointestinal tract lining, triggering a localised immune response and inflammation in the gut wall itself. At the same time, the systemic inflammatory response driven by infection disrupts the intestinal environment from the outside in.
Borrelia has been detected in gastrointestinal tissue. When the bacterium invades the gut lining, it triggers chronic local inflammation and damages the tight junction proteins that maintain the integrity of the intestinal barrier — one of the pathways through which leaky gut develops in Lyme patients.
Elevated inflammatory cytokines impair gut motility (the rhythmic contractions that move food through the digestive tract) and alter the balance of the microbiome. Slowed motility allows bacteria to accumulate in the small intestine, creating the conditions for SIBO.
Antibiotics are necessary for Lyme treatment but carry a significant cost to the microbiome. They eliminate beneficial bacteria alongside pathogens, reducing microbial diversity and creating space for harmful organisms — including Candida and SIBO-associated bacteria — to proliferate. This disruption does not resolve automatically when treatment ends.
Bartonella and Babesia both affect the gastrointestinal tract. Bartonella invades the lining of blood vessels throughout the gut. Babesia drives a pattern of systemic inflammation that compounds gut disruption further. Each co-infection adds its own layer of complexity.
Gastrointestinal symptoms in tick-borne illness
The following symptoms are commonly reported by patients with Lyme disease and co-infections. Their presence alongside other systemic symptoms — fatigue, joint pain, neurological involvement — strengthens the case for investigation of an infectious or inflammatory underlying cause.
Common symptoms
- Nausea — particularly in the morning or after meals, without a clear dietary cause
- Bloating and abdominal distension — often worse in the afternoon or after eating carbohydrates
- Alternating constipation and diarrhoea, or an irritable bowel pattern that does not respond to standard treatment
- Abdominal cramping or discomfort that comes and goes, sometimes severe
- Acid reflux, heartburn, or oesophageal discomfort without structural cause
- Decreased appetite, early satiety, or food aversions
- Food sensitivities that appear or multiply during the illness — particularly to gluten, dairy, or high-FODMAP foods
- Flatulence, particularly shortly after eating or in the morning
- Significant unexplained weight loss, or difficulty maintaining weight
- Symptoms that worsen noticeably during antibiotic treatment (herx-related gut disruption)
- Fatigue and low iron or B12 levels that do not respond to supplementation alone
A study published in Gut Pathogens found that patients presenting to a gastroenterology clinic with unexplained digestive symptoms had a significantly elevated rate of vector-borne illness. Five digestive symptoms were independently associated with positive tick-borne disease testing: food intolerance, indigestion, nausea, constipation, and heartburn. The presence of three or more symptoms — digestive or non-digestive — was found to warrant investigation for tick-borne illness.
SIBO — small intestinal bacterial overgrowth
SIBO is the condition most consistently associated with Lyme disease in gastroenterological research. Under normal circumstances, the small intestine contains very few bacteria. In SIBO, bacteria migrate from the large intestine into the small intestine and begin fermenting foods that should be absorbed before they reach them.
One gastroenterology practice that screened patients for tick-borne illness found SIBO rates as high as 81% in that population. Conservative estimates across the literature suggest 60–70% of Lyme patients have SIBO. SIBO in turn accounts for approximately 60–70% of irritable bowel syndrome diagnoses — meaning many IBS patients may have an underlying cause that has not been investigated.
The hallmark symptoms are bloating (often severe and appearing rapidly after eating), abdominal distension, excessive gas, cramping, and alternating bowel patterns. Symptoms are typically worse after eating bread, pasta, grains, or sugary foods. Malabsorption is common — patients frequently have low iron and low B12 despite adequate intake, because overgrowth bacteria are consuming nutrients before absorption can occur.
The lactulose breath test (LBT) is the most commonly used test. The patient drinks a solution of lactulose and breathes into collection tubes every 20 minutes for several hours. If bacteria are present in the small intestine, they ferment the lactulose and produce detectable gases — hydrogen, methane, or hydrogen sulphide. A rise in these gases in the first 80–90 minutes indicates SIBO. The test must be requested specifically — it is not part of standard GI workup.
SIBO is treated with targeted antibiotics (rifaximin is commonly used as it acts locally in the gut) or herbal antimicrobial protocols that have shown comparable efficacy in research. Probiotics, dietary modification (particularly low-FODMAP approaches during treatment), and motility agents are used supportively. SIBO tends to recur if its underlying cause — impaired gut motility, ongoing infection, microbiome disruption — is not also addressed.
Leaky gut — intestinal permeability
The intestinal lining is a selective barrier: it allows nutrients to pass into the bloodstream while preventing bacteria, toxins, and undigested particles from doing the same. This barrier depends on tight junction proteins that connect adjacent cells in the gut wall. When these proteins are disrupted — by inflammation, infection, or microbial overgrowth — the barrier becomes permeable.
Bacteria that enter the bloodstream through a leaky gut carry a molecule called lipopolysaccharide (LPS), which is highly inflammatory. The immune system responds to LPS with a strong, systemic inflammatory reaction — one of the mechanisms through which gut disruption amplifies inflammation throughout the rest of the body.
Both direct Borrelia invasion of the gut lining and systemic cytokine inflammation compromise the tight junction proteins. SIBO compounds this further — inflammation from bacterial overgrowth in the small intestine strips away the protective mucosal layer. Food sensitivities often develop or worsen as a result, as the immune system begins reacting to food particles entering the bloodstream through the damaged lining.
Lyme disease creates gut inflammation → gut inflammation creates leaky gut → leaky gut drives systemic inflammation → systemic inflammation worsens gut disease. This is why gut health is so difficult to restore during active infection, and why it requires sustained, active support even after antimicrobial treatment has concluded.
L-glutamine is an amino acid used by intestinal cells as their primary fuel source; supplementation supports repair of the gut lining. Zinc carnosine has research support for tight junction integrity. Collagen-rich broth provides building blocks for connective tissue repair. Reducing dietary triggers — sugar, gluten, inflammatory oils — removes ongoing irritants while repair processes are active. These are supportive measures that complement, not replace, treatment of the underlying infection.
MCAS — mast cell activation syndrome
Mast cells are immune cells positioned throughout the body at interfaces between the internal environment and the outside world — in the skin, the lungs, and the gastrointestinal tract. In mast cell activation syndrome, these cells become over-reactive, releasing histamine and other mediators in response to stimuli that would not normally trigger them.
MCAS is increasingly recognised as a companion condition in Lyme disease and co-infections. Chronic immune dysregulation appears to prime mast cells toward a state of persistent hyperreactivity. Patients experience a wide and confusing range of symptoms that appear and disappear without obvious pattern — because the triggers can be almost anything.
MCAS symptoms involving the gut and beyond
- Nausea and heartburn — the most common gastrointestinal MCAS symptoms
- Abdominal pain, cramping, or diarrhoea triggered by foods, smells, temperature changes, or stress
- Widespread food reactivity that appears suddenly and changes over time
- Flushing, skin redness, or hives without clear allergic trigger
- Rapid heartbeat or palpitations after eating certain foods
- Brain fog or anxiety that worsens unpredictably
- Reactions to medications, supplements, or environmental exposures others tolerate normally
MCAS requires specialist investigation for accurate diagnosis. It is not the same as a standard food allergy and is not reliably identified by standard allergy testing. A low-histamine diet often reduces symptom burden significantly. Antihistamines (both H1 and H2 blockers) are commonly used alongside specific mast cell stabilisers. Addressing the underlying Lyme infection is central to long-term improvement — MCAS driven by chronic infection rarely fully resolves without treating the infection itself.
The gut-brain axis — how gut disruption affects the mind
The gut and the brain are in constant two-way communication through the vagus nerve, the immune system, and the blood. The gut produces approximately 90% of the body's serotonin and large quantities of other neurotransmitters. When the microbiome is disrupted and the gut lining is permeable, this production is altered — and the resulting changes in neurotransmitter balance reach the brain.
This is the biological basis for the mood disturbance, anxiety, brain fog, and cognitive difficulties that many Lyme patients experience alongside digestive symptoms. These are not secondary or psychological consequences of being unwell — they are direct downstream effects of gut disruption on brain chemistry. Addressing gut health is therefore not separate from addressing neurological and psychiatric symptoms.
A 2020 study published in mBio (Johns Hopkins) found a distinct microbiome signature in patients with posttreatment Lyme disease syndrome that differed significantly from healthy controls. This suggests that gut disruption is not simply a side effect of antibiotic treatment — it is a persistent feature of the illness itself, with implications for ongoing symptoms long after treatment has concluded.
When gut symptoms come first — and Lyme is missed
For a significant number of patients, gastrointestinal symptoms appear before — or without — the more "classic" symptoms of Lyme disease. These patients may spend years being investigated and treated for IBS, functional dyspepsia, or food intolerances, without anyone considering an infectious or tick-borne cause.
IBS is a diagnosis of exclusion — given when other causes have been ruled out. But Lyme disease is not routinely included in that exclusion process. Standard gastroenterology workup does not include testing for tick-borne illness. If a patient has unexplained, treatment-resistant IBS alongside systemic symptoms — fatigue, joint involvement, cognitive difficulties, or mood changes — tick-borne illness deserves to be part of the differential diagnosis.
Document the full picture: all symptoms across all body systems, their timeline, and whether they fluctuate. The pattern matters more than any individual symptom. A physician experienced in tick-borne illness will look at the whole picture — a gastroenterologist focused only on the gut may not.
Supporting gut health during Lyme treatment
Gut health cannot be fully restored while the underlying infection remains active — but it can be actively supported throughout treatment in ways that reduce symptom burden, improve treatment tolerance, and create better conditions for recovery. These measures are supportive, not treatments for infection, and should be discussed with your physician.
Take probiotics at least two hours away from any antibiotic dose — ideally in the middle of the dosing schedule if you are dosing twice daily. Probiotics taken too close to an antibiotic are simply killed before they can colonise. Continue for several weeks after treatment ends. Multi-strain products with guaranteed colony counts at point of purchase are preferable.
Reducing sugar and refined carbohydrates removes the primary food source of dysbiotic bacteria and Candida. A low-FODMAP approach during SIBO treatment reduces fermentable substrates and relieves bloating. Removing gluten and dairy during acute treatment is commonly recommended. Increasing fibre gradually — from vegetables, legumes, and whole grains — feeds beneficial bacteria once dysbiosis is being treated. Gradually is key: too much fibre too quickly in the presence of SIBO can worsen symptoms.
L-glutamine (3–5g daily), zinc carnosine, and collagen-rich foods support intestinal barrier repair. These are best used after the acute infection burden has been reduced, as the gut cannot repair effectively under active inflammatory siege.
Yeast overgrowth is extremely common during and after antibiotic treatment. Symptoms include increased bloating, sugar cravings, white coating on the tongue, and sometimes vaginal or skin yeast infections. A low-sugar diet is the most important intervention. Probiotics containing Saccharomyces boulardii specifically help in reducing Candida overgrowth.
Healing mentality checkpoint
It is tempting to focus all attention on the antimicrobial part of treatment and treat everything else as secondary. But the gut is where 70–80% of the immune system lives. If the gut is severely disrupted, immune function is compromised, inflammation is amplified, and the nervous system is affected. Supporting gut health is not an optional add-on — it is part of how the body is able to respond to treatment at all.
This does not mean adding twenty supplements and following a perfect protocol. It means making consistent, simple choices — in food, in probiotic timing, in reducing what fuels dysbiosis — and returning to them reliably, even on the difficult days.
Read about healing mentality →Sources & further reading
- Project Lyme — Gastrointestinal Symptoms of Lyme Disease (projectlyme.org)
- Global Lyme Alliance — Lyme Disease, the Gut Microbiome, and Inflammation
- Global Lyme Alliance — Leaky Gut and Lyme Disease
- Sapi E et al. — A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients, mBio, 2020
- Choudhury S et al. — Association of Presenting Symptoms with Abnormal Lab Values for Vector-Borne Illness, Gut Pathogens, 2021
- Dr. Todd Maderis — Gastrointestinal Symptoms of Lyme Disease (drtoddmaderis.com)
- Horowitz R. — Why Can't I Get Better? (2013)
Last updated: March 2026